COSCIENS Biopharma Inc. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2024-03-13 | 2.710 | 2.750 | 2.580 | 2.750 | 33.000 | 2,800 |
| 2024-03-12 | 2.570 | 3.180 | 2.570 | 2.720 | 32.640 | 7,050 |
| 2024-03-08 | 2.610 | 2.610 | 2.610 | 2.610 | 31.320 | 105 |
| 2024-03-07 | 2.630 | 2.630 | 2.460 | 2.460 | 29.520 | 4,160 |
| 2024-03-06 | 2.640 | 2.640 | 2.580 | 2.580 | 30.960 | 1,822 |
| 2024-03-05 | 2.560 | 2.560 | 2.520 | 2.520 | 30.240 | 744 |
| 2024-03-04 | 2.650 | 2.650 | 2.570 | 2.570 | 30.840 | 204 |
| 2024-03-01 | 2.620 | 2.630 | 2.620 | 2.630 | 31.560 | 410 |
| 2024-02-29 | 2.550 | 2.690 | 2.490 | 2.630 | 31.560 | 7,580 |
| 2024-02-28 | 2.550 | 2.550 | 2.550 | 2.550 | 30.600 | 300 |
| 2024-02-27 | 2.640 | 2.640 | 2.500 | 2.500 | 30.000 | 1,805 |
| 2024-02-26 | 2.600 | 2.680 | 2.490 | 2.650 | 31.800 | 11,670 |
| 2024-02-23 | 2.340 | 2.570 | 2.340 | 2.570 | 30.840 | 13,400 |
| 2024-02-22 | 2.330 | 2.330 | 2.290 | 2.290 | 27.480 | 765 |
| 2024-02-21 | 2.400 | 2.460 | 2.400 | 2.400 | 28.800 | 1,200 |
| 2024-02-16 | 2.420 | 2.440 | 2.410 | 2.420 | 29.040 | 1,520 |
| 2024-02-13 | 2.410 | 2.410 | 2.410 | 2.410 | 28.920 | 200 |
| 2024-02-09 | 2.400 | 2.400 | 2.400 | 2.400 | 28.800 | 640 |
| 2024-02-08 | 2.300 | 2.300 | 2.300 | 2.300 | 27.600 | 943 |
| 2024-02-07 | 2.350 | 2.350 | 2.350 | 2.350 | 28.200 | 102 |
| 2024-02-06 | 2.400 | 2.430 | 2.350 | 2.410 | 28.920 | 400 |
| 2024-02-05 | 2.440 | 2.440 | 2.280 | 2.400 | 28.800 | 550 |
| 2024-02-02 | 2.400 | 2.430 | 2.400 | 2.430 | 29.160 | 400 |
| 2024-02-01 | 2.360 | 2.390 | 2.340 | 2.390 | 28.680 | 1,100 |
| 2024-01-31 | 2.520 | 2.520 | 2.520 | 2.520 | 30.240 | 100 |
| 2024-01-30 | 2.600 | 2.600 | 2.600 | 2.600 | 31.200 | 420 |
| 2024-01-29 | 2.480 | 2.500 | 2.450 | 2.500 | 30.000 | 3,477 |
| 2024-01-26 | 2.550 | 2.550 | 2.550 | 2.550 | 30.600 | 100 |
| 2024-01-25 | 2.560 | 2.610 | 2.540 | 2.610 | 31.320 | 300 |
| 2024-01-23 | 2.590 | 2.590 | 2.560 | 2.560 | 30.720 | 308 |
| 2024-01-22 | 2.630 | 2.630 | 2.630 | 2.630 | 31.560 | 508 |
| 2024-01-19 | 2.630 | 2.630 | 2.630 | 2.630 | 31.560 | 140 |
| 2024-01-18 | 2.550 | 2.550 | 2.550 | 2.550 | 30.600 | 108 |
| 2024-01-17 | 2.650 | 2.650 | 2.600 | 2.600 | 31.200 | 310 |
| 2024-01-16 | 2.750 | 2.750 | 2.600 | 2.600 | 31.200 | 2,463 |
| 2024-01-15 | 2.810 | 2.810 | 2.720 | 2.720 | 32.640 | 401 |
| 2024-01-12 | 2.750 | 2.790 | 2.750 | 2.790 | 33.480 | 379 |
| 2024-01-11 | 2.830 | 2.910 | 2.800 | 2.840 | 34.080 | 600 |
| 2024-01-10 | 2.910 | 3.060 | 2.860 | 2.930 | 35.160 | 1,100 |
| 2024-01-09 | 2.600 | 3.000 | 2.600 | 2.890 | 34.680 | 3,864 |
| 2024-01-08 | 2.650 | 2.650 | 2.650 | 2.650 | 31.800 | 500 |
| 2024-01-05 | 2.690 | 2.690 | 2.580 | 2.580 | 30.960 | 680 |
| 2024-01-04 | 2.630 | 2.630 | 2.630 | 2.630 | 31.560 | 100 |
| 2024-01-03 | 2.520 | 2.610 | 2.520 | 2.610 | 31.320 | 500 |
| 2024-01-02 | 2.510 | 2.540 | 2.500 | 2.540 | 30.480 | 2,960 |
| 2023-12-29 | 2.540 | 2.570 | 2.540 | 2.570 | 30.840 | 440 |
| 2023-12-28 | 2.490 | 2.570 | 2.490 | 2.550 | 30.600 | 1,836 |
| 2023-12-27 | 2.530 | 2.530 | 2.380 | 2.400 | 28.800 | 6,028 |
| 2023-12-22 | 2.610 | 2.670 | 2.520 | 2.570 | 30.840 | 3,200 |
| 2023-12-21 | 2.620 | 2.650 | 2.620 | 2.650 | 31.800 | 629 |
| 2023-12-20 | 2.750 | 2.750 | 2.680 | 2.680 | 32.160 | 820 |
| 2023-12-19 | 2.830 | 2.830 | 2.750 | 2.750 | 33.000 | 500 |
| 2023-12-18 | 2.860 | 2.860 | 2.790 | 2.790 | 33.480 | 2,412 |
| 2023-12-15 | 2.850 | 2.850 | 2.850 | 2.850 | 34.200 | 700 |
| 2023-12-14 | 2.910 | 2.910 | 2.860 | 2.880 | 34.560 | 1,400 |
| 2023-12-13 | 2.730 | 2.900 | 2.730 | 2.900 | 34.800 | 2,126 |
| 2023-12-12 | 2.810 | 2.810 | 2.800 | 2.800 | 33.600 | 400 |
| 2023-12-11 | 3.220 | 3.220 | 2.760 | 2.760 | 33.120 | 1,297 |
| 2023-12-08 | 3.090 | 3.240 | 2.980 | 2.980 | 35.760 | 900 |
| 2023-12-07 | 3.200 | 3.200 | 3.200 | 3.200 | 38.400 | 801 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (CAD). Adjusted close accounts for splits and dividends. Educational only, not financial advice.